Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 20Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Leukemia 16Hodgkin Disease 15Multiple Myeloma 14Lymphoma 14Lymphoma, Mantle-Cell 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Follicular 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 10Primary Myelofibrosis 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myelomonocytic, Chronic 9Neoplasms, Plasma Cell 8Leukemia, Myelomonocytic, Juvenile 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Congenital Abnormalities 8Anemia, Refractory, with Excess of Blasts 8Sezary Syndrome 7Mycosis Fungoides 7Blast Crisis 7Myeloproliferative Disorders 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Myeloid, Chronic-Phase 6

Interventions

Cyclophosphamide 9fludarabine 8Interleukin-2 8aldesleukin 7Sunitinib 6Everolimus 6Bevacizumab 6fludarabine phosphate 5Sorafenib 5Radiotherapy 4Nivolumab 4Gene Expression Profiling 4Filgrastim 4pembrolizumab 3peginterferon alfa-2b 3Stem Cell Transplantation 3Radiotherapy, Intensity-Modulated 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3cabozantinib 2atezolizumab 2Thiotepa 2Sodium Chloride 2Reverse Transcriptase Polymerase Chain Reaction 2Polymerase Chain Reaction 2Mycophenolic Acid 2Mesna 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Kidney Neoplasms × Mycophenolic Acid × Clear all
NCT00303719 2020-05-12

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
342 enrolled 14 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Kidney Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT00243009 2012-05-28

Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery

OHSU Knight Cancer Institute

Phase 2 Terminated
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡